Sub-$1 Watch: 10 Stocks That Could Explode — August 23, 2026

Introduction Sub-$1 stocks often attract speculative traders due to their potential for explosive growth. These micro-cap stocks can deliver significant returns, especially when catalysts align. Below is a list of 10 stocks currently trading below $1 that exhibit promising characteristics for traders willing to embrace the risk.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.84 - **Sector**: Cannabis - **Volume Profile**: Increasing volume indicates accumulation over the past month. - **Short Interest**: 15% of the float is shorted, indicating potential for a squeeze. - **Catalyst**: Federal cannabis legalization discussions could provide a significant uplift. - **Technical Setup**: Bouncing off a strong support level at $0.75. - **Risk Factors**: Regulatory changes could negatively impact operations. - **Bull Case Price Target**: $1.20 (30-90 days) - **Risk Rating**: 🟡 High

2. MVIS - Microvision, Inc. - **Current Price**: $0.96 - **Sector**: Technology - **Volume Profile**: Volume has surged by 40% over the last week. - **Short Interest**: 25% of the float, creating a substantial short squeeze potential. - **Catalyst**: Upcoming product launch for automotive LIDAR systems. - **Technical Setup**: Recently broke above a consolidation zone at $0.85. - **Risk Factors**: Competition in the LIDAR space is fierce. - **Bull Case Price Target**: $1.50 (30-90 days) - **Risk Rating**: 🔴 Very High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.92 - **Sector**: Healthcare - **Volume Profile**: Consistent volume growth suggests institutional interest. - **Short Interest**: 18% of shares are shorted, indicating potential for a squeeze. - **Catalyst**: Upcoming quarterly earnings report could exceed expectations. - **Technical Setup**: Currently testing resistance at $1.00. - **Risk Factors**: Regulatory scrutiny in the healthcare sector poses risks. - **Bull Case Price Target**: $1.25 (30-90 days) - **Risk Rating**: 🟡 High

4. ZOM - Zomedica Corp. - **Current Price**: $0.73 - **Sector**: Biotechnology - **Volume Profile**: Volume has increased by 30% over the past month. - **Short Interest**: 20% of float is shorted, creating squeeze potential. - **Catalyst**: FDA approval for a new veterinary diagnostic product. - **Technical Setup**: Bouncing off support at $0.65. - **Risk Factors**: Regulatory delays could hamper progress. - **Bull Case Price Target**: $1.00 (30-90 days) - **Risk Rating**: 🟢 Moderate

5. IFXY - InfuSystem Holdings, Inc. - **Current Price**: $0.95 - **Sector**: Healthcare - **Volume Profile**: Volume increasing steadily, indicating accumulation. - **Short Interest**: 10% of shares are shorted. - **Catalyst**: Expansion of services in home healthcare. - **Technical Setup**: Currently breaking out from a descending triangle. - **Risk Factors**: Market competition can impact growth. - **Bull Case Price Target**: $1.30 (30-90 days) - **Risk Rating**: 🟡 High

6. NAKD - Naked Brand Group Limited - **Current Price**: $0.65 - **Sector**: Apparel - **Volume Profile**: Significant increase in volume following recent news. - **Short Interest**: 22% short interest indicates potential for a squeeze. - **Catalyst**: New product line launch and e-commerce expansion. - **Technical Setup**: Currently testing resistance at $0.70. - **Risk Factors**: Market volatility can impact sales. - **Bull Case Price Target**: $1.00 (30-90 days) - **Risk Rating**: 🔴 Very High

7. GTE - Gran Tierra Energy Inc. - **Current Price**: $0.73 - **Sector**: Energy - **Volume Profile**: Recent spike in volume suggests accumulation. - **Short Interest**: 12% of the float is shorted. - **Catalyst**: Rising oil prices and operational updates from new drilling. - **Technical Setup**: Approaching key resistance at $0.80. - **Risk Factors**: Oil price fluctuations can impact revenue. - **Bull Case Price Target**: $1.00 (30-90 days) - **Risk Rating**: 🟡 High

8. AABB - Asian American International, Inc. - **Current Price**: $0.45 - **Sector**: Gold Mining - **Volume Profile**: Volume has doubled in recent sessions. - **Short Interest**: 15% short interest, indicating potential for a squeeze. - **Catalyst**: Rising gold prices and acquisition news. - **Technical Setup**: Recently rebounded from a major support level at $0.40. - **Risk Factors**: Gold price volatility may impact performance. - **Bull Case Price Target**: $0.75 (30-90 days) - **Risk Rating**: 🟢 Moderate

9. HCMC - Healthier Choices Management Corp. - **Current Price**: $0.30 - **Sector**: Consumer Goods - **Volume Profile**: Increasing volume suggests accumulation. - **Short Interest**: 10% of the float is shorted. - **Catalyst**: Legal victory concerning intellectual property could boost shares. - **Technical Setup**: Holding above support at $0.25. - **Risk Factors**: Legal risks may deter investors. - **Bull Case Price Target**: $0.50 (30-90 days) - **Risk Rating**: 🔴 Very High

10. TTOO - T2 Biosystems, Inc. - **Current Price**: $0.55 - **Sector**: Biotechnology - **Volume Profile**: Recent volume spikes indicate renewed interest. - **Short Interest**: 20% of shares are shorted. - **Catalyst**: Upcoming FDA submission for a new diagnostic test. - **Technical Setup**: Testing support at $0.50. - **Risk Factors**: FDA rejection could lead to significant losses. - **Bull Case Price Target**: $0.85 (30-90 days) - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Low-float, low-price stocks often experience extreme volatility, which can lead to rapid price movements. Their small market capitalization means that even modest buying pressure can lead to significant percentage gains. Additionally, these stocks may have lower barriers to entry for retail investors, creating a more dynamic trading environment.

How to Trade Them Safely Risk management is crucial when trading sub-$1 stocks. Consider using limit orders to control entry prices and avoid slippage. Position sizing should be conservative; allocate only a small percentage of your portfolio to each trade. Monitor catalyst timing closely, as news can create sharp price movements.

Catalyst Calendar - **SNDL**: Federal legalization discussions (Q3 2026) - **MVIS**: Product launch (August 2026) - **CLOV**: Earnings report (September 2026) - **ZOM**: FDA approval (September 2026) - **IFXY**: Home healthcare expansion announcement (August 2026) - **NAKD**: Product line launch (August 2026) - **GTE**: Quarterly operational update (August 2026) - **AABB**: Acquisition news (August 2026) - **HCMC**: Legal updates (September 2026) - **TTOO**: FDA submission (August 2026)

Educational content only. Not financial advice. DYOR.